Efficacy and safety of androgen receptor inhibitors for treatment of advanced prostate cancer: A systematic review and network meta-analysis.

Shichao XiaoHang YinXin LvZhen WangLili JiangYangliu XiaYong Liu

Published in: British journal of clinical pharmacology (2024)

This NMA indicates there is no one ARI to reach both the most effective and safe therapy aims for treating advanced PC and that there is a compromise between the efficacy and safety of ARIs in the treatment of advanced PC. Physicians should weigh the risks to safety against the anticipated benefits when prescribing these drugs to patients with PC.

Keyphrases

prostate cancer
primary care
radical prostatectomy
mesenchymal stem cells
risk assessment
replacement therapy
bone marrow
human health
climate change
electronic health record